Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0030
+0.0030 (299,900.00%)
At close: Aug 7, 2025
Eastgate Biotech Revenue
Eastgate Biotech had revenue of $23.14K in the quarter ending September 30, 2017. This brings the company's revenue in the last twelve months to $137.64K, up 45,325.08% year-over-year.
Revenue (ttm)
137.64K
Revenue Growth
+45,325.08%
P/S Ratio
23.06
Revenue / Employee
45.88K
Employees
3
Market Cap
3.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | - | - | - |
Dec 31, 2015 | 132.03K | - | - |
Dec 31, 2014 | - | - | - |
Dec 31, 2013 | - | - | - |
Dec 31, 2012 | - | - | - |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Glass House Brands | 221.55M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |